Christopher J. Yeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christopher J. Yeh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ata S. Moshiri
The Ronald O. Perelman Department of Dermatology New York University Grossman School of Medicine New York New York USA
1 shared publication - Brian C. Capell
Abramson Cancer Center, CAMB Graduate Group, Department of Dermatology, Cutaneous Phenomics and Transcriptomics Core, Penn SBDRC, Perelman School of Medicine, University of Pennsylvania, Room 1011 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA
1 shared publication - Cem Attilasoy
Abramson Cancer Center, CAMB Graduate Group, Department of Dermatology, Cutaneous Phenomics and Transcriptomics Core, Penn SBDRC, Perelman School of Medicine, University of Pennsylvania, Room 1011 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA
1 shared publication - Corbett T. Berry
Abramson Cancer Center, CAMB Graduate Group, Department of Dermatology, Cutaneous Phenomics and Transcriptomics Core, Penn SBDRC, Perelman School of Medicine, University of Pennsylvania, Room 1011 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, USA
1 shared publication - John T. Seykora
Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
1 shared publication - Matthew L. Hedberg
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 415 Curie Blvd, Philadelphia, PA 19104, USA
1 shared publication
Latest Publications
- Open Access
- 23 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3478
Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma
Non-melanoma skin cancers are cutaneous malignancies representing the most common form of cancer in the United States. They are comprised predominantly of basal cell carcinomas and squamous cell carcinomas (cSCC). The incidence of cSCC is increasing, resulting in substantial morbidity and ever higher treatment costs; currently in excess of one billion dollars, per annum. Here, we review research defining the molecular basis and development of cSCC that aims to provide new insights into pathogenesis and drive the development of novel, cost and morbidity saving therapies.
- 23 March 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (7) , 3478
Open AccessMolecular Mechanisms of Cutaneous Squamous Cell Carcinoma
Non-melanoma skin cancers are cutaneous malignancies representing the most common form of cancer in the United States. They are comprised predominantly of basal cell carcinomas and squamous cell carcinomas (cSCC). The incidence of cSCC is increasing, resulting in substantial morbidity and ever higher treatment costs; currently in excess of one billion dollars, per annum. Here, we review research defining the molecular basis and development of cSCC that aims to provide new insights into pathogenesis and drive the development of novel, cost and morbidity saving therapies.